These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38163859)

  • 1. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
    Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
    J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction enhances the chemotherapeutic sensitivity of colorectal cancer stem cells by miR-320d/c-Myc axis.
    Liu C; Wang JL; Wu DZ; Yuan YW; Xin L
    Mol Cell Biochem; 2022 Jul; 477(7):2001-2013. PubMed ID: 35394639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer.
    Lin H; Luo Y; Gong T; Fang H; Li H; Ye G; Zhang Y; Zhong M
    Cell Oncol (Dordr); 2024 Aug; 47(4):1149-1165. PubMed ID: 38386232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
    Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
    Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
    Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Li J; Li X; Cen C; Ai X; Lin C; Hu G
    Oncol Rep; 2018 Jan; 39(1):217-226. PubMed ID: 29115526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
    Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
    Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer.
    Qin J; Hu S; Lou J; Xu M; Gao R; Xiao Q; Chen Y; Ding M; Pan Y; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112487. PubMed ID: 38889513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB.
    Xu R; Du A; Deng X; Du W; Zhang K; Li J; Lu Y; Wei X; Yang Q; Tang H
    J Exp Clin Cancer Res; 2024 Aug; 43(1):230. PubMed ID: 39153969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF.
    Saeinasab M; Bahrami AR; González J; Marchese FP; Martinez D; Mowla SJ; Matin MM; Huarte M
    J Exp Clin Cancer Res; 2019 Apr; 38(1):172. PubMed ID: 31014355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.